| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2002 | EP1216222A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 06/26/2002 | EP1216221A2 Rxr modulators with improved pharmacologic profile |
| 06/26/2002 | EP1216069A1 Method and cycler for peritoneal dialysis |
| 06/26/2002 | EP1216067A1 Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation |
| 06/26/2002 | EP1216066A1 Compositions for the treatment of wound contracture |
| 06/26/2002 | EP1216059A2 Composition for ivf |
| 06/26/2002 | EP1216057A1 Stable calcitriol solution for packaging in vials |
| 06/26/2002 | EP1216052A1 Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
| 06/26/2002 | EP1216050A2 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 06/26/2002 | EP1216048A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 06/26/2002 | EP1216047A2 Novel combination of loteprednol and beta2-adrenoceptor agonists |
| 06/26/2002 | EP1216046A2 Novel combination of loteprednol and antihistamines |
| 06/26/2002 | EP1216045A2 Vasopressin agonist formulation and process |
| 06/26/2002 | EP1216044A1 Compositions having improved stability |
| 06/26/2002 | EP1216043A1 Retard form containing alpha-lipoic acid (derivatives) |
| 06/26/2002 | EP1216042A1 Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| 06/26/2002 | EP1216041A2 High lipid diet |
| 06/26/2002 | EP1216040A1 Agents for reducing cholesterol-uptake and lipid-uptake |
| 06/26/2002 | EP1216038A2 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 06/26/2002 | EP1216037A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 06/26/2002 | EP1216036A1 Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines |
| 06/26/2002 | EP1216033A1 Vasopressin antagonist formulation and process |
| 06/26/2002 | EP1216032A1 Oral controlled release formulations |
| 06/26/2002 | EP1216031A2 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 06/26/2002 | EP1216030A1 Anti-inflammatory pharmaceutical formulations |
| 06/26/2002 | EP1216026A1 Compositions of tocol-soluble therapeutics |
| 06/26/2002 | EP1216025A1 Dispersion formulations containing lipase inhibitors |
| 06/26/2002 | EP1216024A1 Formulation for menopausal women |
| 06/26/2002 | EP1216019A1 No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product |
| 06/26/2002 | EP1215963A2 Methods for treating neuropathic pain using hetreoarylmethanesulfonamides |
| 06/26/2002 | EP1185948A4 Method for screening and producing compound libraries |
| 06/26/2002 | EP1165067A4 A process for the preparation of aziridinyl epothilones from oxiranyl epothilones |
| 06/26/2002 | EP1105383A4 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 06/26/2002 | EP1051155B1 Nasal solutions |
| 06/26/2002 | EP1049689B1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 06/26/2002 | EP1037609A4 Aqueous insecticidal pour-on formulation |
| 06/26/2002 | EP1037531A4 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 06/26/2002 | EP1007072A4 Glial cell line-derived neurotrophic factor receptors |
| 06/26/2002 | EP1003517B1 Pharmaceutical composition for the treatment of so-called restless legs |
| 06/26/2002 | EP1003510A4 Method for treating headache pain with topical local anesthetic compositions |
| 06/26/2002 | EP0998288B1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 06/26/2002 | EP0973506B1 Process for preparing solid pharmaceutical dosage forms |
| 06/26/2002 | EP0956011B1 Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia |
| 06/26/2002 | EP0941065B1 Ionophore-mediated liposome loading of weakly basic drug |
| 06/26/2002 | EP0931067B1 D4 receptor selectivity piperazine derivatives |
| 06/26/2002 | EP0930878B1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 06/26/2002 | EP0912895A4 Method for monitoring t-cell reactivity |
| 06/26/2002 | EP0906120B1 Compositions comprising a combination of bone morphogenetic protein and parathyroid hormone-related peptide |
| 06/26/2002 | EP0906114B1 Antipsoriatic compositions comprising an asphodelus extract, method of making, and method of using |
| 06/26/2002 | EP0906096B1 Use of hydroxyprolines for the manufacture of a medicament for inhibiting leukocyte invasion of tissues |
| 06/26/2002 | EP0896530B1 Dosage forms and uses |
| 06/26/2002 | EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists |
| 06/26/2002 | EP0888114B1 Use of (+)-alpha-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| 06/26/2002 | EP0877614B1 Method for inducing death of neoplastic cells using piperazine oxirane derivatives |
| 06/26/2002 | EP0822812B1 Topical treatment and prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines |
| 06/26/2002 | EP0820441B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 06/26/2002 | EP0813537B1 Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives |
| 06/26/2002 | EP0778026B1 Remedy for endotoxinemia and multiple organ failure induced thereby |
| 06/26/2002 | EP0771206B1 Hard tissue stimulating agent |
| 06/26/2002 | EP0754050B1 Anti gram positive bacterial methods and materials |
| 06/26/2002 | EP0692963B1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 06/26/2002 | EP0691814B1 Method and composition for treatment of osteoporosis |
| 06/26/2002 | EP0644773B1 Anti-aids immunomodulator complex |
| 06/26/2002 | EP0640077B1 Oxazolidinones containing a substituted diazine moiety and their use as antimicrobials |
| 06/26/2002 | EP0580790B1 Method for potentiating primary drugs in treating multidrug resistant cells |
| 06/26/2002 | CN1355850A Hyaluronidase from hirudinaria manillensis, isolation, purification and recombinant method of production |
| 06/26/2002 | CN1355811A Integrain receptor antagaonists |
| 06/26/2002 | CN1355809A Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 06/26/2002 | CN1355807A Thiazoloindolinone compounds |
| 06/26/2002 | CN1355805A Thienopyrimidines compound |
| 06/26/2002 | CN1355802A Substituted porphyrins |
| 06/26/2002 | CN1355801A Thiazolidinedione derivative and its use as antidiabetic |
| 06/26/2002 | CN1355800A Thiazolidinedione derivative and use as antidiabetic |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355798A 苯并咪唑化合物结晶 Benzimidazole compound crystallized |
| 06/26/2002 | CN1355790A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |
| 06/26/2002 | CN1355789A Indigoid bisindole derivatives |
| 06/26/2002 | CN1355788A 前列腺素e1衍生物 E1 prostaglandin derivative |
| 06/26/2002 | CN1355784A Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 06/26/2002 | CN1355782A Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
| 06/26/2002 | CN1355710A Combination vaccine against streptocouus pneumoniae and repiratory syncytial virus (RSV) |
| 06/26/2002 | CN1355708A HCV combination therapy containing ribavirin in association with antioxidants |
| 06/26/2002 | CN1355706A 因子 Factor |
| 06/26/2002 | CN1355703A Therapeutical agent |
| 06/26/2002 | CN1355702A Use of arylalkanoylpyridazines |
| 06/26/2002 | CN1355701A Urea substituted imidazoquinolines |
| 06/26/2002 | CN1355700A 皮肤麻醉剂 Skin anesthetic |
| 06/26/2002 | CN1355699A Antifungal compositions |
| 06/26/2002 | CN1355698A Compound for medicine for treating function of bronchial contraction |
| 06/26/2002 | CN1355697A IL-8 receptor antagonists |
| 06/26/2002 | CN1355696A Method to aid smoking cessation |
| 06/26/2002 | CN1355695A Compounds useful in reducing level of insulin like growth factor-I (IGF-I) in blood |
| 06/26/2002 | CN1355694A Measalazine controlled redease oral pharmaceutical compositions |
| 06/26/2002 | CN1355693A Controlled release and taste masking oral pharmaceutical compositions |
| 06/26/2002 | CN1355691A Antibody and polyalkylene glycol-bonded liposome |
| 06/26/2002 | CN1355690A Method for improving half-life of soluble viral-specific ligands on mucosal membranes |
| 06/26/2002 | CN1355689A Methods for regulating condition of mammalian keratinous tissue |
| 06/26/2002 | CN1355687A Anhydrous antiperspirant cream compositions having improved perfume longevity |
| 06/26/2002 | CN1355686A Micropigment mixture |